Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0000950170-24-029542

Director sold 2,092 shares at $45.69 ($95,583)

  • Director gave up 1,408 shares (to pay taxes)
  • Director acquired 3,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

GAROFALO ELIZABETH A. · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2024-03-08 Exercise or conversion : show line 1 in the form +3,500 $18.56 $64,960 3,500 D
2024-03-08 Shares withheld for taxes : show line 2 in the form −1,408 $46.16 $64,993 2,092 D
2024-03-08 Sale : show line 3 in the form −2,092 $45.69 $95,583 0 D
Open-market sales · 2,092 sh · avg $45.69 · $95,583

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-03-08 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) −3,500 16,500 D
Loading xslF345X05/ownership.xml…